ArticleThe American journal of tropical medicine and hygiene2025
Risk Factors Associated with Oral Candidiasis in Pemphigus Vulgaris Patients: Results from a Case-Control Study in India.
Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pemphigus vulgaris (PV) is a life-threatening chronic autoimmune mucocutaneous disorder managed by corticosteroids and other immunosuppressive agents. Oral candidiasis (OC) is the most common opportunistic infection in PV. This study aimed to identify the risk factors associated with OC in PV patients. This case-control study included adult cases with PV and healthy controls. Cases with a history of antifungals within the last 2 weeks were excluded. Potential risk factors based on demographics, clinical activity, and laboratory markers including neutrophil/lymphocyte ratio (NLR) and platelet/lymphocyte ratio (PLR) were documented. Seventy-four adult PV cases and healthy controls were included over a period of 18 months. A total of 59.4% (n = 44) of the cases were diagnosed with OC, whereas oral colonization with Candida was present in 8.1% (n = 6) of the controls. Females had 2.7 times higher odds of developing OC than males (P-value = 0.046). Cases with a history of prior topical steroid use had 2.5 times higher odds of developing OC (P-value <0.0001). Cases with a history of prior systemic antibiotic use had 1.8 times higher odds of developing OC (P-value <0.0001). Mean ± SD of NLR and PLR in patients with OC were significantly higher than in cases without OC (P-value <0.0001). OC was not associated with diabetes, oral steroids, or immunosuppressant use in PV in our study. In PV, female gender, prior topical steroid, and systemic antibiotic usage are significant risk factors for the development of OC. NLR and PLR are important laboratory markers that indicate increased predisposition to OC in PV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.